BCBA/ABBV (BCBA/ABBV)

Buenos Aires Stock Exchange: BCBA/ABBV · ARS

ARS 47,520

+142.13 (+0.3%)· Recorded snapshot

Market cap	780.8T
Revenue (ttm)	95.4T
Net income (ttm)	9.3T
EPS (ttm)	ARS 544
P/E (trailing)	87.3x
P/E (forward)	19.1x
Dividend	ARS 729 (1.53%)
Volume	614

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 95.4T
Net income (ttm): 9.3T
EPS (ttm): ARS 544
P/E (trailing): 87.3x
P/E (forward): 19.1x
Market cap: 780.8T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E19.1

P25 n/aP50 n/aP75 n/a

Trailing P/E87.3

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROIC17.7

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All BCBA/ABBV indicators

Market & fundamental data

Available fields

240

Groups with data

Currency

USD

Showing 240 of 240 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	ARS
Country	United States
Country code	AR
Earnings date	2026-10-30
Employees	57,000
Employees change	5,000
Employees growth	10%
Enterprise value	ARS 879.8T
Exchange	Buenos Aires Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2012
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	ARBCOM4603M9
Last earnings date	2026-07-31
Last refreshed	2026-10-28
Market cap	ARS 780.8T
Next earnings date	2026-10-30
Price	ARS 47,520.00
Price currency	ARS
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-28
Symbol	bcba/ABBV
Website	https://www.abbvie.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	41.3x
Average P/E ratio (3Y)	81.44x
Average P/E ratio (5Y)	58.76x
Earnings yield	1.15%
EV/Earnings	94.46x
EV/EBIT	24.92x
EV/EBITDA	18.31x
EV/FCF	32.52x
EV/Sales	8.86x
FCF / EV yield	3.07%
FCF yield	3.47%
Forward P/E	19.06x
Lynch fair value	ARS 2,826.82
Lynch upside	-94.03%
P/(FCF - SBC) ratio	30.49x
P/(OCF - SBC) ratio	28.36x
P/E ratio	87.27x
P/FCF ratio	28.86x
P/OCF ratio	26.94x
P/S ratio	8.16x
Price/EBITDA ratio	17.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.56%
EBITDA margin	47.78%
Effective tax rate	27.39%
FCF margin	27.24%
Gross margin	72.79%
Operating margin	35.56%
Pretax margin	13.51%
Profit margin	9.8%
Profit per employee	ARS 163M
Profitable quarters	6
Profitable years	17
Revenue per employee	ARS 1.7B
ROA	10.51%
ROA (5Y)	8.68%
ROCE	24.49%
ROE (5Y)	1,295.17%
ROIC	17.7%
ROIC (5Y)	21.99%
SBC / revenue	1.52%
Tax / revenue	3.7%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	68.54%
EPS growth (Q)	290.39%
EPS growth (QoQ)	422.72%
EPS growth 10Y	0.21%
EPS growth 3Y	-10.05%
EPS growth 5Y	-0.92%
EPS growth quarters	1
EPS growth years	0
FCF growth	-0.16%
FCF growth (Q)	-36.24%
FCF growth (QoQ)	-12.63%
FCF growth 3Y	-9.78%
FCF growth 5Y	-1.43%
Gross profit growth	12.78%
Gross profit growth (Q)	14.64%
Gross profit growth 3Y	5.88%
Gross profit growth 5Y	5.07%
Net income growth	67.69%
Net income growth (Q)	285.18%
Net income growth (QoQ)	424.16%
Net income growth 3Y	-10.12%
Net income growth 5Y	-1.02%
Net income growth quarters	1
Net income growth years	0
OCF growth	1.16%
OCF growth (Q)	-33.32%
OCF growth (QoQ)	-10.26%
OCF growth 10Y	9.1%
OCF growth 3Y	-8.59%
OCF growth 5Y	-0.94%
Operating income growth	21.17%
Operating income growth (Q)	17.54%
Operating income growth 3Y	3.56%
Operating income growth 5Y	3.75%
Revenue growth	10.39%
Revenue growth (Q)	10.16%
Revenue growth (QoQ)	13.25%
Revenue growth 10Y	10.03%
Revenue growth 3Y	4.75%
Revenue growth 5Y	3.69%
Revenue growth quarters	10
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	ARS -1.9T
Depreciation and amortization	ARS 12.1T
EBIT	ARS 33.9T
EBITDA	ARS 45.6T
EPS	ARS 544.49
Financing cash flow	ARS -19.1T
Free cash flow	ARS 27T
Free cash flow minus SBC	ARS 25.5T
Gross profit	ARS 69.4T
Income taxes	ARS 3.5T
Investing cash flow	ARS -9.6T
Net borrowing	ARS 643B
Net cash flow	ARS 151.1B
Net income	ARS 9.3T
Operating cash flow minus SBC	ARS 27.5T
Operating income	ARS 33.9T
Revenue	ARS 95.4T
Stock-based compensation	ARS 1.4T

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	2.42
Book value per share	ARS -4,975.87
Debt / EBITDA	2.28
Debt / FCF	3.89
Goodwill	ARS 54.6T
Interest coverage	7.85
Long-term assets	ARS 148.4T
Long-term liabilities	ARS 144.8T
Net cash (debt)	ARS -95.3T
Net cash / market cap	-12.24%
Net debt / EBITDA	2.09
Net debt / FCF	3.53
Piotroski F-Score	8
Property, plant and equipment	ARS 8.9T
Shareholders' equity	ARS -8.7T
Tangible book value	ARS -134.2T
Tangible book value per share	ARS -75,952.61
Total assets	ARS 200.2T
Total cash	ARS 9.7T
Total debt	ARS 105T
Total liabilities	ARS 208.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.47
Current assets	ARS 51.8T
Current liabilities	ARS 64.1T
Current ratio	0.81
Inventory turnover	3.47
Net working capital	ARS -9.2T
Quick ratio	0.49
Working capital	ARS -11.8T
Working capital turnover	-10,323.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.03%
Dividend growth	44.94%
Dividend growth (3Y)	85.87%
Dividend growth years	4
Dividend payment date	2026-11-16
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	ARS 728.54
Dividend yield	1.53%
Ex-dividend date	2026-10-15
Last dividend	ARS 261.94
Payout ratio	189.83%
Shareholder yield	1.51%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	ARS 37,474.27
1D price change	0.3%
1M price change	11.13%
1M total return	11.77%
1W price change	1.19%
1W total return	1.19%
1Y price change	43.39%
1Y return CAGR	46.26%
1Y total return	46.22%
20-day SMA	ARS 45,205.00
200-day SMA	ARS 36,418.80
3M price change	15.56%
3M total return	16.23%
3Y price change	297.32%
3Y return CAGR	61.38%
3Y total return	320.39%
50-day SMA	ARS 43,146.80
50-day SMA vs 200-day SMA	50over200
52-week high	ARS 48,420.00
52-week high date	2026-10-26
52-week low	ARS 29,100.00
52-week low date	2026-04-29
5Y price change	2,078.32%
5Y return CAGR	88.27%
5Y total return	2,264.11%
6M price change	58.51%
6M total return	60.1%
All-time high	ARS 48,420.00
All-time high date	2026-10-26
All-time low	ARS 1,501.00
All-time low date	2021-03-25
Average true range (ATR)	ARS 1,044.48
Average volume	2.2K
Change from 52-week high	-1.86%
Change from 52-week low	63.3%
Change from all-time high	-1.86%
Change from all-time low	3,065.89%
Change from open	1.15%
Day's gap	-0.84%
Dollar volume	ARS 29.2M
High price	ARS 47,920.00
Low price	ARS 46,820.00
Monthly RSI	80.52
Open price	ARS 46,980.00
Position in 52-week range	63.64%
Previous close	ARS 47,380.00
Price vs 150-day SMA	26.81%
Price vs 20-day SMA	5.12%
Price vs 200-day SMA	30.48%
Price vs 50-day SMA	10.14%
Relative volume	0.28
RSI	70.12
Sharpe ratio	1.07
Sharpe ratio (3Y)	1.36
Sharpe ratio (5Y)	1.84
Sortino ratio	1.76
Sortino ratio (3Y)	2.15
Sortino ratio (5Y)	2.91
Volume	614
Weekly RSI	74.72
YTD price change	36.47%
YTD total return	39.17%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.8B
Shares change (QoQ)	-0.23%
Shares change (YoY)	0.03%
Shares held by insiders	0.07%
Shares held by institutions	76.58%
Short ratio	3.2 days

Deeper analysis on BCBA/ABBV

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this BCBA/ABBV report

Is a complete BCBA/ABBV research report available?

No complete published report is available for bcba/ABBV (BCBA/ABBV) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

BCBA/ABBV (BCBA/ABBV)

Price

Financial snapshot

Fair-value bridge

Latest news · BCBA/ABBV

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BCBA/ABBV indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on BCBA/ABBV

Frequently asked questions